secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2022-02-18T23:59:59+00:00
Accession:  0001104659-22-025072
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott recalls Similac infant formula from Sturgis MI plant; reaffirms EPS guidance
--------------------------------------------------------------------------------

- Proactive voluntary recall of Similac powder infant formulas from Sturgis, MI facility; primarily US and Canada.
- FY2022 adjusted diluted EPS guidance reaffirmed at at least $4.70.
- Q1 2022 will include one-time specified item for recall expenses (inventory destruction, etc.); amount not yet quantified.
- Company states recall expenses are not expected to have a material impact on consolidated financial statements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000110465922025072/0001104659-22-025072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000110465922025072/tm227088d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-025072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer